{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:44:11Z","timestamp":1790192651111,"version":"4.1.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T00:00:00Z","timestamp":1654473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T00:00:00Z","timestamp":1654473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH102313"],"award-info":[{"award-number":["R01MH102313"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH102313"],"award-info":[{"award-number":["R01MH102313"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH102313"],"award-info":[{"award-number":["R01MH102313"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH102313"],"award-info":[{"award-number":["R01MH102313"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH102313"],"award-info":[{"award-number":["R01MH102313"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH102313"],"award-info":[{"award-number":["R01MH102313"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Social cognitive impairments are core features of schizophrenia spectrum disorders (SSD) and are associated with greater functional impairment and decreased quality of life. Metabolic disturbances have been related to greater impairment in general neurocognition, but their relationship to social cognition has not been previously reported. In this study, metabolic measures and social cognition were assessed in 245 participants with SSD and 165 healthy comparison subjects (HC), excluding those with hemoglobin A1c (HbA1c)\u2009&gt;\u20096.5%. Tasks assessed emotion processing, theory of mind, and social perception. Functional connectivity within and between social cognitive networks was measured during a naturalistic social task. Among SSD, a significant inverse relationship was found between social cognition and cumulative metabolic burden (\n                    <jats:italic>\u03b2<\/jats:italic>\n                    \u2009=\u2009\u22120.38,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001) and HbA1c (\n                    <jats:italic>\u03b2<\/jats:italic>\n                    \u2009=\u2009\u22120.37,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). The relationship between social cognition and HbA1c was robust across domains and measures of social cognition and after accounting for age, sex, race, non-social neurocognition, hospitalization, and treatment with different antipsychotic medications. Negative connectivity between affect sharing and motor resonance networks was a partial mediator of this relationship across SSD and HC groups (\n                    <jats:italic>\u03b2<\/jats:italic>\n                    \u2009=\u2009\u22120.05,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.008). There was a group\u2009x\u2009HbA1c effect indicating that SSD participants were more adversely affected by increasing HbA1c. Thus, we provide the first report of a robust relationship in SSD between social cognition and abnormal glucose metabolism. If replicated and found to be causal, insulin sensitivity and blood glucose may present as promising targets for improving social cognition, functional outcomes, and quality of life in SSD.\n                  <\/jats:p>","DOI":"10.1038\/s41398-022-02002-z","type":"journal-article","created":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T13:02:38Z","timestamp":1654520558000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Metabolic disturbances, hemoglobin A1c, and social cognition impairment in Schizophrenia spectrum disorders"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4001-8120","authenticated-orcid":false,"given":"Sunny X.","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2163-7257","authenticated-orcid":false,"given":"Lindsay D.","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"H\u00e4nsel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"DeRosse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majnu","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar","family":"Khairullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0109-9554","authenticated-orcid":false,"given":"James M.","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Buchanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0156-0395","authenticated-orcid":false,"given":"Aristotle","family":"Voineskos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil K.","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,6]]},"reference":[{"key":"2002_CR1","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/S0140-6736(13)61611-6","volume":"382","author":"HA Whiteford","year":"2013","unstructured":"Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382:1575\u201386.","journal-title":"Lancet"},{"key":"2002_CR2","first-page":"357","volume":"12","author":"HY Chong","year":"2016","unstructured":"Chong HY, Teoh SL, Wu DBC, Kotirum S, Chiou CF, Chaiyakunapruk N. Global economic burden of schizophrenia: a systematic review. Neuropsychiatr Dis Treat. 2016;12:357\u201373.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2002_CR3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/schbul\/sbl029","volume":"32","author":"SM Couture","year":"2006","unstructured":"Couture SM, Penn DL, Roberts DL. The functional significance of social cognition in schizophrenia: a review. Schizophr Bull. 2006;32:44\u201363.","journal-title":"Schizophr Bull"},{"key":"2002_CR4","doi-asserted-by":"publisher","unstructured":"Schmidt SJ, Mueller DR, Roder V. Social cognition as a mediator variable between neurocognition and functional outcome in schizophrenia: Empirical review and new results by structural equation modeling. Schizophr Bull. 2011;37. https:\/\/doi.org\/10.1093\/schbul\/sbr079.","DOI":"10.1093\/schbul\/sbr079"},{"key":"2002_CR5","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1093\/schbul\/sby114","volume":"45","author":"LD Oliver","year":"2019","unstructured":"Oliver LD, Haltigan JD, Gold JM, Foussias G, DeRosse P, Buchanan RW, et al. Lower- and higher-level social cognitive factors across individuals with schizophrenia spectrum disorders and healthy controls: relationship with neurocognition and functional outcome. Schizophr Bull. 2019;45:629\u201338.","journal-title":"Schizophr Bull"},{"key":"2002_CR6","doi-asserted-by":"publisher","first-page":"100171","DOI":"10.1016\/j.scog.2019.100171","volume":"20","author":"K Miley","year":"2020","unstructured":"Miley K, Fisher M, Nahum M, Howard E, Rowlands A, Brandrett B, et al. Six month durability of targeted cognitive training supplemented with social cognition exercises in schizophrenia. Schizophr Res Cogn. 2020;20:100171.","journal-title":"Schizophr Res Cogn"},{"key":"2002_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.schres.2017.07.013","volume":"203","author":"WP Horan","year":"2019","unstructured":"Horan WP, Green MF. Treatment of social cognition in schizophrenia: Current status and future directions. Schizophr Res. 2019;203:3\u201311.","journal-title":"Schizophr Res"},{"key":"2002_CR8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/eip.12834","volume":"14","author":"SX Tang","year":"2020","unstructured":"Tang SX, Seelaus KH, Moore TM, Taylor J, Moog C, O\u2019Connor D, et al. Theatre improvisation training to promote social cognition: A novel recovery-oriented intervention for youths at clinical risk for psychosis. Early Inter Psychiatry. 2020;14:163\u201371.","journal-title":"Early Inter Psychiatry"},{"key":"2002_CR9","doi-asserted-by":"crossref","unstructured":"Ettinger U, Hurlemann R, Chan RCK. Oxytocin and schizophrenia spectrum disorders. In: Current Topics in Behavioral Neurosciences. Springer Verlag, 2018, p. 515\u201327.","DOI":"10.1007\/7854_2017_27"},{"key":"2002_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.neubiorev.2017.05.007","volume":"80","author":"ER Bradley","year":"2017","unstructured":"Bradley ER, Woolley JD. Oxytocin effects in schizophrenia: reconciling mixed findings and moving forward. Neurosci Biobehav Rev 2017;80:36\u201356.","journal-title":"Neurosci Biobehav Rev"},{"key":"2002_CR11","first-page":"E1","volume":"11004","author":"K Hagi","year":"2021","unstructured":"Hagi K, Nosaka T, Dickinson D, Lindenmayer JP, Lee J, Friedman J, et al. Association between cardiovascular risk factors and cognitive impairment in people with schizophrenia: a systematic review and meta-analysis. JAMA Psychiatry. 2021;11004:E1\u2013E9.","journal-title":"JAMA Psychiatry"},{"key":"2002_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0141075","volume":"10","author":"RJM Van Donkersgoed","year":"2015","unstructured":"Van Donkersgoed RJM, Wunderink L, Nieboer R, Aleman A, Pijnenborg GHM. Social cognition in individuals at ultra-high risk for psychosis: a meta-analysis. PLoS ONE. 2015;10:1\u201316.","journal-title":"PLoS ONE"},{"key":"2002_CR13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.schres.2015.02.008","volume":"164","author":"TY Lee","year":"2015","unstructured":"Lee TY, Hong SB, Shin NY, Kwon JS. Social cognitive functioning in prodromal psychosis: a meta-analysis. Schizophr Res. 2015;164:28\u201334.","journal-title":"Schizophr Res"},{"key":"2002_CR14","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1093\/schbul\/sbq171","volume":"38","author":"MF Green","year":"2012","unstructured":"Green MF, Bearden CE, Cannon TD, Fiske AP, Hellemann GS, Horan WP, et al. Social cognition in schizophrenia, part 1: Performance across phase of illness. Schizophr Bull. 2012;38:854\u201364.","journal-title":"Schizophr Bull"},{"key":"2002_CR15","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/schbul\/sbs080","volume":"39","author":"GN Savla","year":"2013","unstructured":"Savla GN, Vella L, Armstrong CC, Penn DL, Twamley EW. Deficits in domains of social cognition in schizophrenia: a meta-analysis of the empirical evidence. Schizophr Bull. 2013;39:979\u201392.","journal-title":"Schizophr Bull"},{"key":"2002_CR16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1001\/jamapsychiatry.2020.3908","volume":"78","author":"LD Oliver","year":"2021","unstructured":"Oliver LD, Moxon-Emre I, Lai MC, Grennan L, Voineskos AN, Ameis SH. Social cognitive performance in schizophrenia spectrum disorders compared with autism spectrum disorder: A Systematic Review, Meta-analysis, and Meta-regression. JAMA Psychiatry. 2021;78:281\u201392.","journal-title":"JAMA Psychiatry"},{"key":"2002_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.147","volume":"6","author":"L Germine","year":"2016","unstructured":"Germine L, Robinson EB, Smoller JW, Calkins ME, Moore TM, Hakonarson H, et al. Association between polygenic risk for schizophrenia, neurocognition and social cognition across development. Transl Psychiatry. 2016;6:e924.","journal-title":"Transl Psychiatry"},{"key":"2002_CR18","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s11682-017-9685-z","volume":"12","author":"Y Saito","year":"2018","unstructured":"Saito Y, Kubicki M, Koerte I, Otsuka T, Rathi Y, Pasternak O, et al. Impaired white matter connectivity between regions containing mirror neurons, and relationship to negative symptoms and social cognition, in patients with first-episode schizophrenia. Brain Imaging Behav. 2018;12:229\u201337.","journal-title":"Brain Imaging Behav"},{"key":"2002_CR19","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1001\/jamapsychiatry.2014.3169","volume":"72","author":"DH Wolf","year":"2015","unstructured":"Wolf DH, Satterthwaite TD, Calkins ME, Ruparel K, Elliott MA, Hopson RD, et al. Functional neuroimaging abnormalities in youth with psychosis spectrum symptoms. JAMA Psychiatry. 2015;72:456\u201365.","journal-title":"JAMA Psychiatry"},{"key":"2002_CR20","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ebiom.2018.07.037","volume":"34","author":"Z Li","year":"2018","unstructured":"Li Z, Chen P, Chen J, Xu Y, Wang Q, Li X, et al. Glucose and insulin-related traits, type 2 diabetes and risk of schizophrenia: a mendelian randomization study. EBioMedicine. 2018;34:182\u20138.","journal-title":"EBioMedicine"},{"key":"2002_CR21","first-page":"11","volume":"2012","author":"EE Lee","year":"2014","unstructured":"Lee EE, Martin AS, Tu X, Palmer BW, Jeste DV. Childhood adversity and schizophrenia: the protective role of resilience in mental and physical health and metabolic markers. J Clin Psychiatry. 2014;2012:11\u201312.","journal-title":"J Clin Psychiatry"},{"key":"2002_CR22","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association\/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112:2735\u201352.","journal-title":"Circulation"},{"key":"2002_CR23","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1001\/archpsyc.64.10.1123","volume":"64","author":"S Saha","year":"2007","unstructured":"Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia. Arch Gen Psychiatry. 2007;64:1123\u201331.","journal-title":"Arch Gen Psychiatry"},{"key":"2002_CR24","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.2337\/dc18-S002","volume":"41","author":"American Diabetes Association.","year":"2018","unstructured":"American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes 2018. Diabetes Care. 2018;41:S13\u2013S27.","journal-title":"Diabetes Care"},{"key":"2002_CR25","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/eip.12866","volume":"14","author":"M Onozato","year":"2020","unstructured":"Onozato M, Umino M, Shoji A, Ichiba H, Tsujino N, Funatogawa T, et al. Serum d- and l-lactate, pyruvate and glucose levels in individuals with at-risk mental state and correlations with clinical symptoms. Early Inter Psychiatry. 2020;14:410\u20137.","journal-title":"Early Inter Psychiatry"},{"key":"2002_CR26","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/s41380-018-0045-1","volume":"24","author":"VA Chouinard","year":"2019","unstructured":"Chouinard VA, Henderson DC, Dalla Man C, Valeri L, Gray BE, Ryan KP, et al. Impaired insulin signaling in unaffected siblings and patients with first-episode psychosis. Mol Psychiatry. 2019;24:1513\u201322.","journal-title":"Mol Psychiatry"},{"key":"2002_CR27","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1017\/S0033291718002738","volume":"49","author":"T Zhang","year":"2019","unstructured":"Zhang T, Xu L, Tang Y, Li H, Tang X, Cui H, et al. Prediction of psychosis in prodrome: development and validation of a simple, personalized risk calculator. Psychol Med. 2019;49:1990\u20138.","journal-title":"Psychol Med"},{"key":"2002_CR28","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1017\/S0033291716003366","volume":"47","author":"E Bora","year":"2017","unstructured":"Bora E, Akdede BB, Alptekin K. The relationship between cognitive impairment in schizophrenia and metabolic syndrome: a systematic review and meta-analysis. Psychol Med. 2017;47:1030\u201340.","journal-title":"Psychol Med"},{"key":"2002_CR29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.schres.2012.09.019","volume":"142","author":"JP Lindenmayer","year":"2012","unstructured":"Lindenmayer JP, Khan A, Kaushik S, Thanju A, Praveen R, Hoffman L, et al. Relationship between metabolic syndrome and cognition in patients with schizophrenia. Schizophr Res. 2012;142:171\u20136.","journal-title":"Schizophr Res"},{"key":"2002_CR30","doi-asserted-by":"publisher","first-page":"112941","DOI":"10.1016\/j.psychres.2020.112941","volume":"288","author":"S Chen","year":"2020","unstructured":"Chen S, Xia X, Deng C, Wu X, Han Z, Tao J, et al. The correlation between metabolic syndrome and neurocognitive and social cognitive performance of patients with schizophrenia. Psychiatry Res. 2020;288:112941.","journal-title":"Psychiatry Res"},{"key":"2002_CR31","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.psychres.2013.06.020","volume":"210","author":"L Boyer","year":"2013","unstructured":"Boyer L, Richieri R, Dassa D, Boucekine M, Fernandez J, Vaillant F, et al. Association of metabolic syndrome and inflammation with neurocognition in patients with schizophrenia. Psychiatry Res. 2013;210:381\u20136.","journal-title":"Psychiatry Res"},{"key":"2002_CR32","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/NMD.0000000000000124","volume":"202","author":"C Li","year":"2014","unstructured":"Li C, Zhan G, Rao S, Zhang H. Metabolic syndrome and its factors affect cognitive function in chronic schizophrenia complicated by metabolic syndrome. J Nerv Ment Dis. 2014;202:313\u20138.","journal-title":"J Nerv Ment Dis"},{"key":"2002_CR33","doi-asserted-by":"publisher","first-page":"9416","DOI":"10.3390\/nu7115477","volume":"7","author":"L Mellendijk","year":"2015","unstructured":"Mellendijk L, Wiesmann M, Kiliaan AJ. Impact of nutrition on cerebral circulation and cognition in the metabolic syndrome. Nutrients 2015;7:9416\u201339.","journal-title":"Nutrients"},{"key":"2002_CR34","doi-asserted-by":"publisher","unstructured":"Zhang X, Yang M, Du X, Liao W, Chen D, Fan F, et al. Glucose disturbances, cognitive deficits and white matter abnormalities in first-episode drug-naive schizophrenia. Mol Psychiatry. 2019. https:\/\/doi.org\/10.1038\/s41380-019-0478-1.","DOI":"10.1038\/s41380-019-0478-1"},{"key":"2002_CR35","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/jmri.26290","volume":"49","author":"M Liang","year":"2019","unstructured":"Liang M, Cai X, Tang Y, Yang XL, Fang J, Li J, et al. Diffusion tensor imaging of white matter in patients with prediabetes by trace-based spatial statistics. J Magn Reson Imaging. 2019;49:1105\u201312.","journal-title":"J Magn Reson Imaging"},{"key":"2002_CR36","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.psyneuen.2014.07.019","volume":"50","author":"L Boyer","year":"2014","unstructured":"Boyer L, Testart J, Michel P, Richieri R, Faget-Agius C, Vanoye V, et al. Neurophysiological correlates of metabolic syndrome and cognitive impairment in schizophrenia: A structural equation modeling approach. Psychoneuroendocrinology. 2014;50:95\u2013105.","journal-title":"Psychoneuroendocrinology"},{"key":"2002_CR37","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ejphar.2004.02.056","volume":"490","author":"AAF Sima","year":"2004","unstructured":"Sima AAF, Kamiya H, Li ZG. Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes. Eur J Pharm. 2004;490:187\u201397.","journal-title":"Eur J Pharm"},{"key":"2002_CR38","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/YCO.0000000000000326","volume":"30","author":"P Falkai","year":"2017","unstructured":"Falkai P, Malchow B, Schmitt A. Aerobic exercise and its effects on cognition in schizophrenia. Curr Opin Psychiatry. 2017;30:171\u20135.","journal-title":"Curr Opin Psychiatry"},{"key":"2002_CR39","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5\u00ae). 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"2002_CR40","first-page":"134","volume":"2","author":"MB First","year":"2004","unstructured":"First MB, Gibbon M. The structured clinical interview for DSM-IV axis I disorders (SCID-I) and the structured clinical interview for DSM-IV axis II disorders (SCID-II). Compr Handb Psychol Assess. 2004;2:134\u201343.","journal-title":"Compr Handb Psychol Assess"},{"key":"2002_CR41","unstructured":"Defining Adult Overweight and Obesity | Overweight & Obesity | CDC. https:\/\/www.cdc.gov\/obesity\/adult\/defining.html (accessed 15 Sep2020)."},{"key":"2002_CR42","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1001\/jamapsychiatry.2014.1314","volume":"71","author":"CU Correll","year":"2014","unstructured":"Correll CU, Robinson DG, Schooler NR, Brunette MF, Mueser KT, Rosenheck RA, et al. Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP study. JAMA Psychiatry. 2014;71:1350\u201363.","journal-title":"JAMA Psychiatry"},{"key":"2002_CR43","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.2337\/diacare.28.11.2745","volume":"28","author":"ES Ford","year":"2005","unstructured":"Ford ES. Prevalence of the metabolic syndrome defined by the international diabetes federation among adults in the U.S. Diabetes Care. 2005;28:2745\u20139.","journal-title":"Diabetes Care"},{"key":"2002_CR44","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1176\/appi.ajp.2007.07010042","volume":"165","author":"KH Nuechterlein","year":"2008","unstructured":"Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD, et al. The MATRICS consensus cognitive battery, part 1: Test selection, reliability, and validity. Am J Psychiatry. 2008;165:203\u201313.","journal-title":"Am J Psychiatry"},{"key":"2002_CR45","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","volume":"10","author":"JE Overall","year":"1962","unstructured":"Overall JE, Gorham DR. The brief psychiatric rating scale. Psychol Rep. 1962;10:799\u2013812.","journal-title":"Psychol Rep"},{"key":"2002_CR46","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1037\/neu0000093","volume":"29","author":"TM Moore","year":"2015","unstructured":"Moore TM, Reise SP, Gur RE, Hakonarson H, Gur RC. Psychometric properties of the penn computerized neurocognitive battery. Neuropsychology. 2015;29:235\u201346.","journal-title":"Neuropsychology"},{"key":"2002_CR47","doi-asserted-by":"crossref","unstructured":"Kern RS, Penn DL, Lee J, \u2026 WPH-S, undefined 2013. Adapting social neuroscience measures for schizophrenia clinical trials, Part 2: trolling the depths of psychometric properties. academic.oup.com.","DOI":"10.1093\/schbul\/sbt127"},{"key":"2002_CR48","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/1469-7610.00715","volume":"42","author":"S Baron-Cohen","year":"2001","unstructured":"Baron-Cohen S, Wheelwright S, Hill J, Raste Y, Plumb I. The \u2018Reading the Mind in the Eyes\u2019 Test revised version: a study with normal adults, and adults with Asperger syndrome or high-functioning autism. J Child Psychol Psychiatry. 2001;42:241\u201351.","journal-title":"J Child Psychol Psychiatry"},{"key":"2002_CR49","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.psychres.2008.03.010","volume":"166","author":"MJ Sergi","year":"2009","unstructured":"Sergi MJ, Fiske AP, Horan WP, Kern RS, Kee KS, Subotnik KL, et al. Development of a measure of relationship perception in schizophrenia. Psychiatry Res. 2009;166:54\u201362.","journal-title":"Psychiatry Res"},{"key":"2002_CR50","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/00001199-200305000-00001","volume":"18","author":"S McDonald","year":"2003","unstructured":"McDonald S, Flanagan S, Rollins J, Kinch J. A new clinical tool for assessing social perception after traumatic brain injury. J Head Trauma Rehabil. 2003;18:219\u201338.","journal-title":"J Head Trauma Rehabil"},{"key":"2002_CR51","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1080\/02664763.2019.1630372","volume":"47","author":"RA Peterson","year":"2020","unstructured":"Peterson RA, Cavanaugh JE. Ordered quantile normalization: a semiparametric transformation built for the cross-validation era. J Appl Stat. 2020;47:2312\u201327.","journal-title":"J Appl Stat"},{"key":"2002_CR52","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/schbul\/sbx117","volume":"44","author":"AE Pinkham","year":"2018","unstructured":"Pinkham AE, Harvey PD, Penn DL. Social cognition psychometric evaluation: results of the final validation study. Schizophr Bull. 2018;44:737\u201348.","journal-title":"Schizophr Bull"},{"key":"2002_CR53","first-page":"1201","volume":"6","author":"LD Oliver","year":"2021","unstructured":"Oliver LD, Hawco C, Homan P, Lee J, Green MF, Gold JM, et al. Social Cognitive Networks and Social Cognitive Performance Across Individuals With Schizophrenia Spectrum Disorders and Healthy Control Participants. Biol Psychiatry Cogn Neurosci Neuroimaging. 2021;6:1201\u201314.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"2002_CR54","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria., 2016."},{"key":"2002_CR55","doi-asserted-by":"publisher","first-page":"5186","DOI":"10.1016\/j.csda.2007.11.008","volume":"52","author":"M Hubert","year":"2008","unstructured":"Hubert M, Vandervieren E. An adjusted boxplot for skewed distributions. Comput Stat Data Anal. 2008;52:5186\u2013201.","journal-title":"Comput Stat Data Anal"},{"key":"2002_CR56","doi-asserted-by":"crossref","unstructured":"L\u00fcdecke D, Dominique M, Waggoner P, Indrajeet P. performance: {Assessment} of {Regression} {Models} {Performance}. 2020.","DOI":"10.32614\/CRAN.package.performance"},{"key":"2002_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i03","volume":"45","author":"S van Buuren","year":"2011","unstructured":"van Buuren S, Groothuis-Oudshoorn K. {mice}: multivariate imputation by chained equations in R. J Stat Softw. 2011;45:1\u201367.","journal-title":"J Stat Softw"},{"key":"2002_CR58","first-page":"1","volume":"48","author":"R Lavaan","year":"2012","unstructured":"Lavaan R. lavaan: an R package for structural equation modeling. J Stat Softw. 2012;48:1\u201336.","journal-title":"J Stat Softw"},{"key":"2002_CR59","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3758\/BRM.40.3.879","volume":"40","author":"K Preacher","year":"2008","unstructured":"Preacher K, Hayes A. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods. 2008;40:879\u201391.","journal-title":"Behav Res Methods"},{"key":"2002_CR60","doi-asserted-by":"publisher","unstructured":"Assuncao N, Sudo FK, Drummond C, De Felice FG, Mattos P. Metabolic syndrome and cognitive decline in the elderly: a systematic review. PLoS ONE. 2018;13. https:\/\/doi.org\/10.1371\/journal.pone.0194990.","DOI":"10.1371\/journal.pone.0194990"},{"key":"2002_CR61","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s11011-015-9700-2","volume":"30","author":"YC Chen","year":"2015","unstructured":"Chen YC, Xia W, Qian C, Ding J, Ju S, Teng GJ. Thalamic resting-state functional connectivity: disruption in patients with type 2 diabetes. Metab Brain Dis. 2015;30:1227\u201336.","journal-title":"Metab Brain Dis"},{"key":"2002_CR62","doi-asserted-by":"publisher","unstructured":"Liu D, Duan S, Zhou C, Wei P, Chen L, Yin X, et al. Altered brain functional hubs and connectivity in type 2 diabetes mellitus patients: a resting-state fMRI study. Front Aging Neurosci. 2018;10. https:\/\/doi.org\/10.3389\/fnagi.2018.00055.","DOI":"10.3389\/fnagi.2018.00055"},{"key":"2002_CR63","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/jdi.12545","volume":"8","author":"T Umemura","year":"2017","unstructured":"Umemura T, Kawamura T, Hotta N. Pathogenesis and neuroimaging of cerebral large and small vessel disease in type 2 diabetes: A possible link between cerebral and retinal microvascular abnormalities. J Diabetes Investig 2017;8:134\u201348.","journal-title":"J Diabetes Investig"},{"key":"2002_CR64","doi-asserted-by":"publisher","unstructured":"Balter LJ, Raymond JE, Aldred S, Higgs S, Bosch JA. Age, BMI, and inflammation: associations with emotion recognition. Physiol Behav. 2021;232. https:\/\/doi.org\/10.1016\/j.physbeh.2021.113324.","DOI":"10.1016\/j.physbeh.2021.113324"},{"key":"2002_CR65","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.schres.2015.08.019","volume":"168","author":"J Joseph","year":"2015","unstructured":"Joseph J, Depp C, Martin AS, Daly RE, Glorioso DK, Palmer BW, et al. Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups. Schizophr Res. 2015;168:456\u201360.","journal-title":"Schizophr Res"},{"key":"2002_CR66","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S2213-8587(14)70148-2","volume":"3","author":"SLC Geijselaers","year":"2015","unstructured":"Geijselaers SLC, Sep SJS, Stehouwer CDA, Biessels GJ. Glucose regulation, cognition, and brain MRI in type 2 diabetes: a systematic review. Lancet Diabetes Endocrinol. 2015;3:75\u201389.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2002_CR67","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.schres.2005.07.015","volume":"80","author":"JM Meyer","year":"2005","unstructured":"Meyer JM, Nasrallah HA, McEvoy JP, Goff DC, Davis SM, Chakos M, et al. The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial: Clinical comparison of subgroups with and without the metabolic syndrome. Schizophr Res. 2005;80:9\u201318.","journal-title":"Schizophr Res"},{"key":"2002_CR68","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.schres.2012.08.034","volume":"142","author":"Y Takayanagi","year":"2012","unstructured":"Takayanagi Y, Cascella NG, Sawa A, Eaton WW. Diabetes is associated with lower global cognitive function in schizophrenia. Schizophr Res. 2012;142:183\u20137.","journal-title":"Schizophr Res"},{"key":"2002_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.comppsych.2015.07.003","volume":"63","author":"BH Zhang","year":"2015","unstructured":"Zhang BH, Han M, Zhang XY, Hui L, Jiang SR, De Yang F, et al. Gender differences in cognitive deficits in schizophrenia with and without diabetes. Compr Psychiatry. 2015;63:1\u20139.","journal-title":"Compr Psychiatry"},{"key":"2002_CR70","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1176\/appi.ajp.2013.12111438","volume":"171","author":"MH Meier","year":"2014","unstructured":"Meier MH, Caspi A, Reichenberg A, Keefe RSE, Fisher HL, Harrington H, et al. Neuropsychological decline in schizophrenia from the premorbid to the postonset period: Evidence from a population-representative longitudinal study. Am J Psychiatry. 2014;171:91\u2013101.","journal-title":"Am J Psychiatry"},{"key":"2002_CR71","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0006-3223(00)00240-7","volume":"48","author":"R Fucetola","year":"2000","unstructured":"Fucetola R, Seidman LJ, Kremen WS, Faraone SV, Goldstein JM, Tsuang MT. Age and neuropsychologic function in schizophrenia: A decline in executive abilities beyond that observed in healthy volunteers. Biol Psychiatry. 2000;48:137\u201346.","journal-title":"Biol Psychiatry"},{"key":"2002_CR72","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3758\/s13415-018-00648-1","volume":"19","author":"C Fernandes","year":"2019","unstructured":"Fernandes C, Gon\u00e7alves AR, Pasion R, Ferreira-Santos F, Barbosa F, Martins IP, et al. Age-related decline in emotional perspective-taking: Its effect on the late positive potential. Cogn Affect Behav Neurosci. 2019;19:109\u201322.","journal-title":"Cogn Affect Behav Neurosci"},{"key":"2002_CR73","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.2044-8295.2011.02040.x","volume":"103","author":"H Rakoczy","year":"2012","unstructured":"Rakoczy H, Harder-Kasten A, Sturm L. The decline of theory of mind in old age is (partly) mediated by developmental changes in domain-general abilities. Br J Psychol. 2012;103:58\u201372.","journal-title":"Br J Psychol"},{"key":"2002_CR74","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.arr.2011.12.001","volume":"11","author":"J Kemp","year":"2012","unstructured":"Kemp J, Despr\u00e9s O, Sellal F, Dufour A. Theory of Mind in normal ageing and neurodegenerative pathologies. Ageing Res Rev. 2012;11:199\u2013219.","journal-title":"Ageing Res Rev"},{"key":"2002_CR75","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/13825585.2015.1048773","volume":"23","author":"LM Lavrencic","year":"2016","unstructured":"Lavrencic LM, Kurylowicz L, Valenzuela MJ, Churches OF, Keage HAD. Social cognition is not associated with cognitive reserve in older adults. Aging Neuropsychol Cogn. 2016;23:61\u201377.","journal-title":"Aging Neuropsychol Cogn"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02002-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02002-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02002-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T10:41:51Z","timestamp":1727347311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02002-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,6]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2002"],"URL":"https:\/\/doi.org\/10.1038\/s41398-022-02002-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.04.01.22273310","asserted-by":"object"}]},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,6]]},"assertion":[{"value":"28 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SXT is a consultant for Neurocrine Biosciences and North Shore Therapeutics, received funding from Winterlight Labs, and holds equity in North Shore Therapeutics. RWB is a DSMB member for Merck, Newron, and Roche; on the advisory board for Acadia, Avanir, Boehringer Ingelheim GBMH, GW Pharma, Minerva, and Roche; and consultant for Boehringer Ingelheim GMBH. AKM is a consultant for Acadia Pharmaceuticals, Genomind Inc, Informed DNA, and Janssen Pharmaceuticals. The other authors have no disclosures to report.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"233"}}